Edition:
United States

People: Genomic Health Inc (GHDX.OQ)

GHDX.OQ on NASDAQ Stock Exchange Global Select Market

63.48USD
4:00pm EDT
Change (% chg)

$1.55 (+2.50%)
Prev Close
$61.93
Open
$61.97
Day's High
$63.70
Day's Low
$61.41
Volume
129,113
Avg. Vol
153,600
52-wk High
$91.03
52-wk Low
$31.13

Cole, Gordon 

Mr. Gordon Bradley Cole serves as Chief Financial Officer, Chief Operating Officer of the Company. Mr. Cole also served as our Chief Operating Officer from January 2009 until March 2018. Prior to these roles, Mr. Cole served as Executive Vice President, Operations from January 2008 until January 2009. Mr. Cole also served as our Secretary from February 2005 until July 2012. From December 1997 to May 2004, he served in various roles at Guidant Corporation, a medical device company, most recently serving as Vice President, Finance and Business Development for the Endovascular Solutions Group from January 2001 until May 2004. From July 1994 to December 1997, Mr. Cole was Vice President, Finance and Chief Financial Officer of Endovascular Technologies, Inc., a medical device company that was acquired by Guidant Corporation. From December 1988 to February 1994, he served as Vice President, Finance and Chief Financial Officer of Applied Biosystems Incorporated, a life sciences systems company. Mr. Cole holds a B.S. in Business from Biola University and an M.B.A. from San Jose State University.

Basic Compensation

Total Annual Compensation, USD 734,270
Restricted Stock Awards, USD 223,687
Long-Term Incentive Plans, USD --
All Other, USD 648,815
Fiscal Year Total, USD 1,606,770

Options Compensation

  Quantity Market Value
Exercisable 59,597 542,929.00
Unexercisable 163,773 1,036,470.00
Exercised 50,710 598,288.00
Name Fiscal Year Total

Kimberly Popovits

4,117,300

Gordon Cole

1,606,770

Steven Shak

1,418,200

Phillip Febbo

--

Laura Kammeyer

--

Frederic Pla

1,588,330
As Of  30 Dec 2017